Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eugene R. Przespolewski
Observed names:
E. Przespolewski,
Eugene Przespolewski,
Eugene R Przespolewski
Institution:
Roswell Park Comprehensive Cancer Center
Observed institutions:
Roswell Park Comprehensive Cancer Center,
Dent Neurologic Institute,
University at Buffalo, State University of New York
ORCID:
0000-0001-8149-7431
Observed ORCID:
0000-0001-8149-7431
OpenAlex ID:
A5084501814
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association
2022
·
Craig J. Beavers
, Jo E. Rodgers
, et al.
·
Circulation
·
187
PDF
Evaluating the Effect of Six Proton Pump Inhibitors on the Antiplatelet Effects of Clopidogrel
2018
·
Eugene R. Przespolewski
, Erica S. Westphal
, et al.
·
Journal of Stroke and Cerebrovascular Diseases
·
33
Treatment Strategies for Advanced Classical Hodgkin Lymphoma in the Times of Dacarbazine Shortage
2022
·
Pallawi Torka
, Eugene Przespolewski
, et al.
·
JCO Oncology Practice
·
14
PDF
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
2022
·
Pallawi Torka
, Adrienne Groman
, et al.
·
Blood Advances
·
10
PDF
Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting?
2024
·
Joseph Elijah
, Prantesh Jain
, et al.
·
Supportive Care in Cancer
·
6
PDF
Concomitant Venetoclax and Imatinib for Comanaging Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia: A Case Report
2023
·
Eugene R. Przespolewski
, Jeffrey Baron
, et al.
·
Journal of the National Comprehensive Cancer Network
·
6
PDF
Ofatumumab plus HyperCVAD/HD‐MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study
2022
·
Pallawi Torka
, Othman S. Akhtar
, et al.
·
Cancer
·
5
PDF
Impact of Social Determinants of Health on Survival Outcomes in Multiple Myeloma Patients at a Major Cancer Center
2024
·
Esraa Abdalla
, Malak Alharbi
, et al.
·
Blood
·
3
Survey of biosimilar adoption across oncology pharmacy practices.
2022
·
Marina Reed
, Eugene Przespolewski
, et al.
·
Journal of Clinical Oncology
·
2
Evaluation of Medication Regimen Complexity ( MRC ) and Pharmacist Interventions Utilizing the MRC ‐ ICU Scoring Tool in Hematology/Oncology Patients: A Cohort Study
2025
·
Allison Holdsworth
, Michael LaPorte
, et al.
·
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
·
1
An assessment of the professional fulfillment of oncology residency program directors
2025
·
Eugene R Przespolewski
, Alharith Abdel-Razzaq
, et al.
·
American Journal of Health-System Pharmacy
·
1
Assessing burnout of pharmacist preceptors in PGY2 oncology residency programs: Results of a national survey
2026
·
Eve Hughes
, Eugene Przespolewski
, et al.
·
American Journal of Health-System Pharmacy
Carfilzomib plus rituximab, ifosfamide, carboplatin and etoposide (C-RICE) led to higher response, OS, and PFS in patients with transplant-eligible relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
2024
·
Mody Amin
, Alex Niu
, et al.
·
Journal of Clinical Oncology
Inotuzumab Ozogamicin + Blinatumumab +/- Rituximab + Mini-Hcvd Shows Improved Tolerability with Similar Efficacy Compared to E1910 in Treatment of Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia in Older Adults
2023
·
Jordan Scott
, Samantha Poblete
, et al.
·
Blood
Real world outcomes of trilaciclib in ES-SCLC.
2023
·
Joseph Elijah
, Allison Holdsworth
, et al.
·
Journal of Clinical Oncology
Retrospective Comparison of the Efficacy and Safety of Lenalidomide, Bortezomib and Dexamethasone (RVD) 21-Day Schedule Vs. 28-Day Schedule in Patients with Newly Diagnosed Multiple Myeloma
2021
·
Alina Varabyeva
, Jens Hillengass
, et al.
·
Blood
Impact of Anticonvulsant - Methotrexate Interactions on High Dose Methotrexate Clearance and Outcomes in Patients with Primary CNS Lymphoma
2021
·
Ilana N Cypes
, Angel Mier-Hicks
, et al.
·
Blood
A Phase 1 Study of Carfilzomib With Rituximab, Ifosfamide, Carboplatin and Etoposide (c‐rice) in Transplant‐eligible Relapsed/refractory Diffuse Large B‐cell Lymphoma
2021
·
P. Torka
, A. Groman
, et al.
·
Hematological Oncology
Evaluating the Clopidogrel-Proton Pump Inhibitor Interaction by Comparing Platelet Aggregation to ADP with Clopidogrel in the Presence of Proton Pump Inhibitors (P5.144)
2015
·
Francis Gengo
, Eugene Przespolewski
, et al.
·
Neurology
Show more works
View as search
Works count:
19
Citation count:
268
H-index:
6
I10-index:
4
Year
Topic
Type